<?xml version="1.0" encoding="UTF-8"?>
<html><body class="spl" id="spl">
<div class="DocumentTitle"><p class="DocumentTitle"><strong>ALOCRIL- nedocromil sodium solution/ drops </strong><br>Allergan, Inc.<br></p></div>
<h1>ALOCRIL<span class="Sup">®</span> (nedocromil sodium ophthalmic solution) 2%</h1>
<div class="Contents">
<div class="Section" data-sectionCode="48780-1">
<a name="dcl-dpl"></a><a name="section-1"></a><p></p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="e1"></a><a name="section-1"></a><p></p>
<p class="First"><span class="Bold">sterile</span></p>
</div>
<div class="Section" data-sectionCode="34089-3">
<a name="s1"></a><a name="section-2"></a><p></p>
<h1>DESCRIPTION</h1>
<p class="First"><span class="Bold">ALOCRIL</span><span class="Sup">®</span> (nedocromil sodium ophthalmic solution) 2% is a clear, yellow, sterile solution for topical ophthalmic use.</p>
<p>Nedocromil sodium is represented by the following structural formula:</p>
<div class="Figure">
<a name="f1"></a><img alt="Structural Formula" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=2fe8d7ad-2158-4169-94b0-719ad20242b7&amp;name=chemicalstructure.jpg">
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="s2"></a><a name="section-2.1"></a><p></p>
<h2>Chemical Name:</h2>
<p class="First">4<span class="Italics">H</span>-Pyrano[3,2-<span class="Italics">g</span>]quinoline-2,8-dicarboxylic acid, 9-ethyl-6,9-dihydro-4,6-dioxo-10-propyl-, disodium salt.</p>
<div class="Section" data-sectionCode="42229-5">
<a name="s3"></a><a name="section-2.1.1"></a><p></p>
<p class="First"><span class="Bold">Each mL contains: Active:</span> Nedocromil sodium 20 mg/mL (2%); <span class="Bold">Preservative:</span> Benzalkonium chloride 0.01%; <span class="Bold">Inactives:</span> Edetate disodium 0.05%, purified water, and sodium chloride 0.5%.  It has a pH range of 4.0 to 5.5 and an <span class="product-label-link" type="condition" conceptid="4197115" conceptname="Osmotic pressure">osmolality</span> range of 270 to 330 mOsm/kg.</p>
</div>
</div>
</div>
<div class="Section" data-sectionCode="34090-1">
<a name="s4"></a><a name="section-3"></a><p></p>
<h1>CLINICAL PHARMACOLOGY</h1>
<p class="First">Nedocromil sodium is a mast cell stabilizer.  Nedocromil sodium inhibits the release of mediators from cells involved in <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity reactions</span>.  Decreased chemotaxis and decreased activation of eosinophils have also been demonstrated.</p>
<p><span class="Italics">In vitro</span> studies with adult human bronchoalveolar cells showed that nedocromil sodium inhibits histamine release from a population of mast cells having been defined as belonging to the mucosal sub type and inhibits beta-glucuronidase release from macrophages.</p>
<div class="Section" data-sectionCode="42229-5">
<a name="s5"></a><a name="section-3.1"></a><p></p>
<h2>Pharmacokinetics and Bioavailability</h2>
<p class="First">Nedocromil sodium exhibits low systemic absorption.  When administered as a 2% ophthalmic solution in adult human volunteers, less than 4% of the total dose was systemically absorbed following multiple dosing.  Absorption is mainly through the nasolacrimal duct rather than through the conjunctiva.  It is not metabolized and is eliminated primarily unchanged in urine (70%) and feces (30%).</p>
</div>
</div>
<div class="Section" data-sectionCode="34067-9">
<a name="s6"></a><a name="section-4"></a><p></p>
<h1>INDICATIONS AND USAGE</h1>
<p class="First"><span class="Bold">ALOCRIL</span><span class="Sup">®</span> ophthalmic solution is indicated for the treatment of <span class="product-label-link" type="condition" conceptid="4302654" conceptname="Itching">itching</span> associated with <span class="product-label-link" type="condition" conceptid="374959" conceptname="Contact blepharoconjunctivitis">allergic conjunctivitis</span>.</p>
</div>
<div class="Section" data-sectionCode="34070-3">
<a name="s7"></a><a name="section-5"></a><p></p>
<h1>CONTRAINDICATIONS</h1>
<p class="First"><span class="Bold">ALOCRIL</span><span class="Sup">®</span> ophthalmic solution is contraindicated in those patients who have shown <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity</span> to nedocromil sodium or to any of the other ingredients.</p>
</div>
<div class="Section" data-sectionCode="42232-9">
<a name="s8"></a><a name="section-6"></a><p></p>
<h1>PRECAUTIONS</h1>
<div class="Section" data-sectionCode="34076-0">
<a name="s9"></a><a name="section-6.1"></a><p></p>
<h2>Information for Patients</h2>
<p class="First">Patients should be advised to follow the patient instructions listed on the Information for Patients sheet.</p>
<p>Users of contact lenses should refrain from wearing lenses while exhibiting the signs and symptoms of <span class="product-label-link" type="condition" conceptid="374959" conceptname="Contact blepharoconjunctivitis">allergic conjunctivitis</span>.</p>
<p>Patients should be instructed to avoid allowing the tip of the dispensing container to contact the eye, surrounding structures, fingers, or any other surface in order to avoid contamination of the solution by common bacteria known to cause ocular <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infections</span>.  Serious damage to the eye and subsequent <span class="product-label-link" type="condition" conceptid="377551" conceptname="Blind hypertensive eye">loss of vision</span> may result from using contaminated solutions.</p>
</div>
<div class="Section" data-sectionCode="34083-6">
<a name="s10"></a><a name="section-6.2"></a><p></p>
<h2>Carcinogenesis, Mutagenesis, and Impairment of Fertility</h2>
<p class="First">A two-year inhalation carcinogenicity study of nedocromil sodium at a dose of 24 mg/kg/day (approximately 400 times the maximum recommended human daily ocular dose on a mg/kg basis) in Wistar rats showed no carcinogenic potential.</p>
<p>Nedocromil sodium showed no mutagenic potential in the Ames <span class="product-label-link" type="condition" conceptid="4235289" conceptname="Salmonellosis">Salmonella</span>/microsome plate assay, mitotic gene conversion in <span class="Italics">Saccharomyces cerevisiae</span>, mouse <span class="product-label-link" type="condition" conceptid="432571" conceptname="Malignant lymphoma">lymphoma</span> forward mutation and mouse micronucleus assays.</p>
<p>Reproduction and fertility studies in mice and rats showed no effects on male and female fertility at a subcutaneous dose of 100 mg/kg/day (more than 1600 times the maximum recommended human daily ocular dose).</p>
</div>
<div class="Section" data-sectionCode="42228-7">
<a name="s11"></a><a name="section-6.3"></a><p></p>
<h2>Pregnancy</h2>
<div class="Section" data-sectionCode="34077-8">
<a name="s12"></a><a name="section-6.3.1"></a><p></p>
<h3><span class="Bold">Teratogenic Effects: Pregnancy Category B</span></h3>
<p class="First">Reproduction studies performed in mice, rats and rabbits using a subcutaneous dose of 100 mg/kg/day (more than 1600 times the maximum human daily ocular dose on a mg/kg basis) revealed no evidence of <span class="product-label-link" type="condition" conceptid="4240324" conceptname="Teratogenesis">teratogenicity</span> or harm to the fetus due to nedocromil sodium.  There are, however, no adequate and well-controlled studies in pregnant women.  Because animal reproduction studies are not always predictive of human response, <span class="Bold">ALOCRIL</span><span class="Sup">®</span> ophthalmic solution should be used during pregnancy only if clearly needed.</p>
</div>
</div>
<div class="Section" data-sectionCode="34080-2">
<a name="s13"></a><a name="section-6.4"></a><p></p>
<h2>Nursing Mothers</h2>
<p class="First">After intravenous administration to lactating rats, nedocromil was excreted in milk.  It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when <span class="Bold">ALOCRIL</span><span class="Sup">®</span> ophthalmic solution is administered to a nursing woman.</p>
</div>
<div class="Section" data-sectionCode="34081-0">
<a name="s14"></a><a name="section-6.5"></a><p></p>
<h2>Pediatric Use</h2>
<p class="First">Safety and effectiveness in children below the age of 3 years have not been established.</p>
</div>
<div class="Section" data-sectionCode="34082-8">
<a name="s15"></a><a name="section-6.6"></a><p></p>
<h2>Geriatric Use</h2>
<p class="First">No overall differences in safety or effectiveness have been observed between elderly and younger patients.</p>
</div>
</div>
<div class="Section" data-sectionCode="34084-4">
<a name="s16"></a><a name="section-7"></a><p></p>
<h1>ADVERSE REACTIONS</h1>
<p class="First">The most frequently reported adverse experience was <span class="product-label-link" type="condition" conceptid="378253" conceptname="Headache">headache</span> (~40%).</p>
<p>Ocular burning, irritation and <span class="product-label-link" type="condition" conceptid="4329041" conceptname="Pain">stinging</span>, unpleasant taste, and <span class="product-label-link" type="condition" conceptid="4195085" conceptname="Nasal congestion">nasal congestion</span> have been reported to occur in 10 – 30% of patients. Other events occurring between 1 – 10% included <span class="product-label-link" type="condition" conceptid="317009" conceptname="Asthma">asthma</span>, <span class="product-label-link" type="condition" conceptid="379019" conceptname="Conjunctivitis">conjunctivitis</span>, <span class="product-label-link" type="condition" conceptid="442546" conceptname="Red eye">eye redness</span>, <span class="product-label-link" type="condition" conceptid="4260194" conceptname="Photophobia">photophobia</span>, and <span class="product-label-link" type="condition" conceptid="4320791" conceptname="Rhinitis">rhinitis</span>.</p>
<p>Some of these events were similar to the underlying ocular disease being studied.</p>
</div>
<div class="Section" data-sectionCode="34068-7">
<a name="s17"></a><a name="section-8"></a><p></p>
<h1>DOSAGE AND ADMINISTRATION</h1>
<p class="First">The recommended dosage is one or two drops in each eye twice a day. <span class="Bold">ALOCRIL</span><span class="Sup">®</span> ophthalmic solution should be used at regular intervals.</p>
<p>Treatment should be continued throughout the period of exposure (i.e., until the pollen season is over or until exposure to the offending allergen is terminated), even when symptoms are absent.</p>
</div>
<div class="Section" data-sectionCode="34069-5">
<a name="s18"></a><a name="section-9"></a><p></p>
<h1>HOW SUPPLIED</h1>
<p class="First"><span class="Bold">ALOCRIL</span><span class="Sup">®</span> (nedocromil sodium ophthalmic solution) 2% is supplied sterile in opaque white LDPE plastic bottles with dropper tips and white high impact polystyrene (HIPS) caps as follows:</p>
<p>5 mL in 10 mL bottle NDC 0023-8842-05</p>
<div class="Section" data-sectionCode="44425-7">
<a name="s19"></a><a name="section-9.1"></a><p></p>
<p class="First"><span class="Bold">Storage:</span> Store at 2º–25º C (36º–77º F).</p>
<p><span class="Bold">Rx only</span></p>
<p><span class="Bold">Revised: 12/2012</span></p>
<p>© 2013 Allergan, Inc.<br>Irvine, CA 92612, U.S.A.<br>® marks owned by Allergan, Inc.<br>
                           Made in the U.S.A.
                        </p>
<p>71761US12</p>
<p><span class="Bold">PHARMACIST - DETACH HERE AND GIVE INSTRUCTIONS TO PATIENTS</span></p>
</div>
</div>
<div class="Section" data-sectionCode="42230-3">
<a name="s20"></a><a name="section-10"></a><p></p>
<h1>Information for the Patient</h1>
<p class="First"><span class="Bold">ALOCRIL</span><span class="Sup">®</span></p>
<p><span class="Bold">(nedocromil sodium ophthalmic solution) 2%<br>sterile</span></p>
<p>It is important to use <span class="Bold">ALOCRIL</span><span class="Sup">®</span> ophthalmic solution regularly, as directed by your physician.</p>
<ol class="Arabic">
<li>Thoroughly wash your hands.</li>
<li>Remove safety seal (<a href="#f2">Figure 1</a>).</li>
<li>Remove cap (<a href="#f3">Figure 2</a>).</li>
<li>Sit or stand comfortably, with your head tilted back (<a href="#f4">Figure 3</a>).</li>
<li>Open eyes, look up, and draw the lower lid of your eye down gently with your index finger (<a href="#f5">Figure 4</a>).</li>
<li>Hold the <span class="Bold">ALOCRIL</span><span class="Sup">®</span> bottle upside down.  Place tip as close as possible to the lower eyelid without touching the tip to the eye, and gently squeeze out the prescribed number of drops (<a href="#f6">Figure 5</a>).</li>
<li>Do not touch the eye or eyelid with the bottle tip.</li>
<li>Blink a few times to make sure the eye is covered with the solution.</li>
<li>Close your eye and remove any excess solution with a clean tissue.</li>
<li>Repeat process in the other eye.</li>
</ol>
<p><span class="Bold">SPECIAL TIPS</span></p>
<ol class="Arabic">
<li>Avoid placing <span class="Bold">ALOCRIL</span><span class="Sup">®</span> ophthalmic solution directly on the cornea (the area just over the pupil), because it is especially sensitive. You will find the administration of eye drops more comfortable if you place the drops just inside the lower eyelid as shown in <a href="#f6">Figure 5</a> on the previous page.</li>
<li>To avoid contamination of the solution, do not touch dropper tip to the eye, fingers, or any other surface. Replace bottle cap after use.  It is recommended that any remaining contents be discarded after treatment period prescribed by your physician.</li>
<li>Store at 2º–25º C (36º–77º F). Store in original carton.</li>
<li>Keep bottle tightly closed and out of the reach of children.</li>
<li>Do not use with any other ocular medication unless directed by your physician. Do not wear contact lenses during treatment with <span class="Bold">ALOCRIL</span><span class="Sup">®</span> ophthalmic solution.</li>
</ol>
<p>© 2013 Allergan, Inc.<br>Irvine, CA 92612, U.S.A.<br>® marks owned by Allergan, Inc.<br>
                     Made in the U.S.A.
                  </p>
<p>71761US12</p>
<div class="Figure">
<a name="f2"></a><img alt="Figure 1" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=2fe8d7ad-2158-4169-94b0-719ad20242b7&amp;name=figure1.jpg"><p class="MultiMediaCaption">Figure 1</p>
</div>
<div class="Figure">
<a name="f3"></a><img alt="Figure 2" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=2fe8d7ad-2158-4169-94b0-719ad20242b7&amp;name=figure2.jpg"><p class="MultiMediaCaption">Figure 2</p>
</div>
<div class="Figure">
<a name="f4"></a><img alt="Figure 3" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=2fe8d7ad-2158-4169-94b0-719ad20242b7&amp;name=figure3.jpg"><p class="MultiMediaCaption">Figure 3</p>
</div>
<div class="Figure">
<a name="f5"></a><img alt="Figure 4" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=2fe8d7ad-2158-4169-94b0-719ad20242b7&amp;name=figure4.jpg"><p class="MultiMediaCaption">Figure 4</p>
</div>
<div class="Figure">
<a name="f6"></a><img alt="Figure 5" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=2fe8d7ad-2158-4169-94b0-719ad20242b7&amp;name=figure5.jpg"><p class="MultiMediaCaption">Figure 5</p>
</div>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="s21"></a><a name="section-11"></a><p></p>
<p class="First">NDC 0023-8842-05
</p>
<p><span class="Bold"><span class="Italics">Alocril</span></span><span class="Sub">®</span><br>(nedocromil sodium<br>ophthalmic solution) 2%
</p>
<p><span class="Bold">STERILE</span></p>
<p><span class="Bold">For topical application in the eye</span></p>
<p><span class="Bold">5 mL</span></p>
<p><span class="Bold">ALLERGAN</span></p>
<div class="Figure">
<a name="f07"></a><img alt="Carton
" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=2fe8d7ad-2158-4169-94b0-719ad20242b7&amp;name=carton.jpg">
</div>
</div>
</div>
<div class="DataElementsTables">
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>ALOCRIL 		
					</strong><br><span class="contentTableReg">nedocromil sodium solution/ drops</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:0023-8842</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">OPHTHALMIC</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">    
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>nedocromil sodium</strong> (nedocromil) </td>
<td class="formItem">nedocromil sodium</td>
<td class="formItem">20 mg  in 1 mL</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>edetate disodium</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>water</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>sodium chloride</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>benzalkonium chloride</strong></td>
<td class="formItem"> </td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:0023-8842-05</td>
<td class="formItem">1  in 1 CARTON</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem"></td>
<td class="formItem">5 mL in 1 BOTTLE, DROPPER</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">NDA</td>
<td class="formItem">NDA021009</td>
<td class="formItem">02/03/2000</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Labeler - </span>Allergan, Inc.
							(144796497)
						</td></tr></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Establishment</span></td></tr>
<tr>
<th scope="col" class="formTitle">Name</th>
<th scope="col" class="formTitle">Address</th>
<th scope="col" class="formTitle">ID/FEI</th>
<th scope="col" class="formTitle">Business Operations</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">Allergan, Inc.</td>
<td class="formItem"></td>
<td class="formItem">144796497</td>
<td class="formItem">MANUFACTURE(0023-8842)</td>
</tr>
</table>
</div>
<p><div class="EffectiveDate">Revised: 12/2012<div class="DocumentMetadata">
<div>
<a href="javascript:toggleMixin();">Document Id: </a>2f35a2aa-54f1-4abb-b1be-056b17a0d3c5</div>
<div>Set id: 2fe8d7ad-2158-4169-94b0-719ad20242b7</div>
<div>Version: 5</div>
<div>Effective Time: 20121210</div>
</div>
</div> <div class="DistributorName">Allergan, Inc.</div></p>
</body></html>
